Literature DB >> 18174357

Progesterone-dependent deoxyribonucleic acid looping between RUSH/SMARCA3 and Egr-1 mediates repression by c-Rel.

Aveline Hewetson1, Beverly S Chilton.   

Abstract

Steroids regulate alternative splicing of RUSH/SMARCA3. The full-length, progesterone-dependent alpha-isoform and the 3'-truncated, estrogen-dependent beta-isoform have identical DNA-binding domains, nuclear localization signals, and RING fingers. Transcription of RUSH/SMARCA3 is mediated by a bipartite progesterone receptor half-site/overlapping Y-box combination (-38/-26), where progesterone activation is attenuated by nuclear factor Y binding. Regulation also involves two GC-rich sequences in the proximal promoter (-162/+90) and a RUSH/SMARCA3 site (-616/-611) in the 5'-untranslated region. Isoform-specific binding to the RUSH/SMARCA3 site is dictated by the hormonal milieu, as is the availability of factors that bind to the distal GC-rich site (-131/-126), a composite binding site for Egr-1/specific protein-1/3/Myc-associated zinc finger protein/myeloid zinc finger-1/c-Rel, and the proximal GC-rich site (-62/-53), which binds only Sp1/3. TransSignal TF-TF interaction arrays, supershift assays, and chromatin immunoprecipitation analyses confirmed strong physical interactions between RUSH/Egr-1 and RUSH/c-Rel that were visualized with fluorescent microscopy. Higher-order, long-range interactions between RUSH and Egr-1/c-Rel derivative of the anisotropic flexibility of the intervening DNA sequence were shown by Chromosome Conformation Capture assay. Glutathione S-transferase pull-downs confirmed that the RING finger is the protein-binding domain, suggesting that the RUSH isoforms have equivalent potential for protein interactions. Transient transfection assays showed that the cooperative interaction between RUSH and Egr-1 mediates repression by c-Rel. Thus, progesterone-induced transcription is fine-tuned by isoform-specific autoregulation, in which newly synthesized RUSH-1alpha binds DNA and interacts physically with liganded Egr-1 in the proximal promoter via a DNA-looping mechanism to mediate repression by c-Rel. In the absence of progesterone induction, RUSH-1beta replaces RUSH-1alpha binding, Egr-1 and c-Rel are unavailable as molecular ties, and DNA looping is disfavored.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174357      PMCID: PMC2276468          DOI: 10.1210/me.2007-0432

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  30 in total

Review 1.  Making the right choice--long-range chromosomal interactions in development.

Authors:  James R Broach
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

Review 2.  DNA looping in gene regulation: from the assembly of macromolecular complexes to the control of transcriptional noise.

Authors:  Jose M G Vilar; Leonor Saiz
Journal:  Curr Opin Genet Dev       Date:  2005-04       Impact factor: 5.578

3.  Repression of lac promoter as a function of distance, phase and quality of an auxiliary lac operator.

Authors:  J Müller; S Oehler; B Müller-Hill
Journal:  J Mol Biol       Date:  1996-03-22       Impact factor: 5.469

4.  Cloning, characterization, and steroid-dependent posttranscriptional processing of RUSH-1 alpha and beta, two uteroglobin promoter-binding proteins.

Authors:  A Hayward-Lester; A Hewetson; E G Beale; P J Oefner; P A Doris; B S Chilton
Journal:  Mol Endocrinol       Date:  1996-11

5.  Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene.

Authors:  H Ding; A M Benotmane; G Suske; D Collen; A Belayew
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

6.  Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.

Authors:  W Wang; L Dong; B Saville; S Safe
Journal:  Mol Endocrinol       Date:  1999-08

Review 7.  Regulation of signal transduction pathways by estrogen and progesterone.

Authors:  Dean P Edwards
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

8.  Egr-1 is activated by 17beta-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1.

Authors:  Chien-Cheng Chen; Wan-Ru Lee; Stephen Safe
Journal:  J Cell Biochem       Date:  2004-11-15       Impact factor: 4.429

9.  Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells.

Authors:  M A Pratt; A Satkunaratnam; D M Novosad
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

10.  Prolactin signals through RUSH/SMARCA3 in the absence of a physical association with Stat5a.

Authors:  Aveline Hewetson; Shelli L Moore; Beverly S Chilton
Journal:  Biol Reprod       Date:  2004-08-11       Impact factor: 4.285

View more
  11 in total

Review 1.  The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor?

Authors:  Ludovic Dhont; Céline Mascaux; Alexandra Belayew
Journal:  Cell Mol Life Sci       Date:  2016-01       Impact factor: 9.261

2.  Prolactin-induced Jak2 phosphorylation of RUSH: a key element in Jak/RUSH signaling.

Authors:  Rebecca A Helmer; Marlyn Panchoo; Janet S Dertien; Suhani M Bhakta; Aveline Hewetson; Beverly S Chilton
Journal:  Mol Cell Endocrinol       Date:  2010-05-26       Impact factor: 4.102

3.  HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter.

Authors:  Mijke Visser; Manfred Kayser; Robert-Jan Palstra
Journal:  Genome Res       Date:  2012-01-10       Impact factor: 9.043

4.  Conservation of inter-protein binding sites in RUSH and RFBP, an ATP11B isoform.

Authors:  Aveline Hewetson; Amber E Wright-Pastusek; Rebecca A Helmer; Kerrie A Wesley; Beverly S Chilton
Journal:  Mol Cell Endocrinol       Date:  2008-05-21       Impact factor: 4.102

5.  Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.

Authors:  Chi Keung Cheng; Natalie P H Chan; Thomas S K Wan; Lai Ying Lam; Coty H Y Cheung; Terry H Y Wong; Rosalina K L Ip; Raymond S M Wong; Margaret H L Ng
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

6.  Quantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytes.

Authors:  Charis L Himeda; Jeffrey A Ranish; Stephen D Hauschka
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

7.  Early growth response 1 loops the CYP2B6 promoter for synergistic activation by the distal and proximal nuclear receptors CAR and HNF4alpha.

Authors:  Kaoru Inoue; Masahiko Negishi
Journal:  FEBS Lett       Date:  2009-05-23       Impact factor: 4.124

8.  Role of helicase-like transcription factor (hltf) in the G2/m transition and apoptosis in brain.

Authors:  Rebecca A Helmer; Oded Foreman; Janet S Dertien; Marlyn Panchoo; Suhani M Bhakta; Beverly S Chilton
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 9.  Functional implications of genome topology.

Authors:  Giacomo Cavalli; Tom Misteli
Journal:  Nat Struct Mol Biol       Date:  2013-03       Impact factor: 15.369

10.  Helicase-like transcription factor (Hltf) regulates G2/M transition, Wt1/Gata4/Hif-1a cardiac transcription networks, and collagen biogenesis.

Authors:  Rebecca A Helmer; Raul Martínez-Zaguilán; Janet S Dertien; Candra Fulford; Oded Foreman; Vasum Peiris; Beverly S Chilton
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.